• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comparison the pathogen diagnosis of severe pneumonia by using next generation sequencing and traditional detection methods, China, 2010-2018

tetano

Editor, Senior Moderator
J Infect. 2018 Sep 17. pii: S0163-4453(18)30277-9. doi: 10.1016/j.jinf.2018.09.004. [Epub ahead of print]
[h=1]Comparison the pathogen diagnosis of severe pneumonia by using next generation sequencing and traditional detection methods, China, 2010-2018.[/h] Xie Y[SUP]1[/SUP], Du J[SUP]1[/SUP], Jin W[SUP]1[/SUP], Teng X[SUP]1[/SUP], Cheng R[SUP]1[/SUP], Huang P[SUP]1[/SUP], Xie H[SUP]1[/SUP], Zhou Z[SUP]1[/SUP], Feng T[SUP]2[/SUP], Tian R[SUP]3[/SUP], Wang R[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Severe pneumonia is one of the most common infectious diseases and can be fatal. The benefits of early pathogen diagnosis in intensive care units are known, but the association between early pathogen diagnosis by next-generation sequencing (NGS) and in-hospital mortality of patients with severe pneumonia has rarely been studied. The study aims to explore the association between early pathogen diagnosis by NGS and the mortality of patients with severe pneumonia admitted to intensive care units, effects of early pathogen diagnosis on ICU and hospital lengths of stay, and other clinical outcome. This is a retrospective study enrolling 178 severe pneumonia patients whose samples were collected between January 2010 and June 2018 in the ICU of Shanghai General Hospital. A total of 130 patients was assigned to conventional detection group (control group) using conventional microbiologic tests to exam sputum, blood, or BAL fluid samples. 48 patients were assigned to early pathogen diagnosis group (NGS group) using NGS to exam samples. Data, including basic information, clinical symptoms, microbiologic test results, laboratory results, APACHE II score, SOFA score, CT and other serum biomarkers, was collected. The mortality, length of stay in hospital, MODS and other complications, time of mechanical ventilation, and etiological diagnosis were compared between two groups.The 28-day and 90-day mortality of NGS group was significantly lower than the control group. The bacterial detection rate of NGS group was significantly higher than the control group, particularly in Streptococcus pneumoniae, Haemophilus influenza and Prevotella melaninogenicus.This study suggests that NGS might lead to more rapid and accurate diagnosis with better clinical prognosis than conventional detection methods in severe pneumonia in ICU.


[h=4]KEYWORDS:[/h] Mortality; Next-generation sequencing; Pathogens diagnosis; Severe pneumonia

PMID: 30237069 DOI: 10.1016/j.jinf.2018.09.004
 
Back
Top Bottom